Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches

Introduction: Renal cell carcinomas (RCC) have been treated with immunotherapy for decades; the use of immune checkpoint inhibitors represents the most recent advance. In this review, we compare these new RCC immunotherapies, with a focus on achieving durable complete responses (CR). Review: Sorafen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kathuria-Prakash, Nikhita, Drolen, Claire, Hannigan, Christopher A., Drakaki, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781308/
https://www.ncbi.nlm.nih.gov/pubmed/35054417
http://dx.doi.org/10.3390/life12010024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781308/
https://www.ncbi.nlm.nih.gov/pubmed/35054417
http://dx.doi.org/10.3390/life12010024

Ejemplares similares